iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionKingsview Wealth Management, LLC
Latest Disclosed Ownership3,641 shares
Latest Disclosed Value $ 614,714
Kingsview Wealth Management, LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Kingsview Wealth Management, LLC filed a 13F-HR form disclosing ownership of 3,641 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $614,714 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,235 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 12.55% during the quarter. The current value of the position is $477,153 USD.

Kingsview Wealth Management, LLC has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,641 406 12.55 615 12.45 0.0084
2026-02-09 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,235 34 1.06 546 18.18 0.0079
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,201 -180 -5.32 462 8.20 0.0071
2025-08-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,381 135 4.16 428 2.89 0.0072
2025-05-02 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,246 -28,838 -89.88 415 -90.21 0.0078
2025-01-28 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 32,084 28,541 805.56 4,242 723.50 0.0826
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,543 438 14.11 516 20.89 0.0108
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,105 284 10.07 426 10.08 0.0101
2024-05-09 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,821 -318 -10.13 387 -9.15 0.0097
2024-02-08 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,139 221 7.57 426 19.66 0.0127
2023-11-07 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,918 -1,167 -28.57 357 -31.27 0.0128
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,085 127 3.21 519 1.37 0.0203
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,958 443 12.60 511 10.85 0.0215
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,515 170 5.08 461 17.90 0.0200
2022-11-15 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,345 -209 -5.88 391 -6.46 0.0185
2022-08-16 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,554 -485 -12.01 418 -20.53 0.0200
2024-02-08 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,039 -847 -17.34 526 -29.49 0.0232
2022-02-17 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,886 396 8.82 746 2.75 0.0310
2021-12-03 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,490 942 26.55 726 23.89 0.0344
2021-08-17 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,548 -42 -1.17 586 7.72 0.0290
2021-05-24 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,590 -454 -11.23 544 -11.26 0.0309
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,044 -1,973 -32.79 613 -24.79 0.0444
2020-11-19 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,017 -7,847 -56.60 815 -56.99 0.0730
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,864 10,737 343.36 1,895 462.31 0.1896
2020-05-11 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,127 317 11.28 337 -0.59 0.0455
2020-01-31 2019-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 2,810 90 3.31 339 25.09 0.0425
2020-01-30 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,743 2,023 506 180,132.0731
2020-01-29 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,720 -494 -15.37 271 -22.79 0.0426
2020-01-29 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,214 -4,290 -57.17 351 -58.16 0.0589
2020-01-29 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,504 4,214 128.09 839 164.67 0.1276
2020-01-29 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,290 268 8.87 317 -14.09 0.0692
2020-01-29 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,022 -150 -4.73 369 6.03 0.0748
2020-01-29 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,172 -17 -0.53 348 2.35 0.0831
2020-01-29 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,189 -1,554 -32.76 340 -32.81 0.0845
2020-01-29 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,743 2,805 144.74 506 -21.67 0.1806
2020-01-29 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,938 644 49.77 646 61.10 0.2842
2020-01-29 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,294 280 27.61 401 35.02 0.2064
2020-01-29 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,014 1,014 297 0.1762
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-11 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 n/a n/a n/a
2020-01-30 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Call 200 0 n/a n/a n/a
2020-01-28 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-29 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Call 400 1 n/a n/a n/a
2020-01-29 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 n/a n/a n/a
2020-01-29 2017-12-31 13F ISHARES TR NASDAQ BIOTECH Call 200 -80.00 0 -100.00 n/a n/a n/a
2020-01-29 2017-09-30 13F ISHARES TR NASDAQ BIOTECH Call 1,000 -88.51 5 -61.54 n/a n/a n/a
2020-01-29 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF Call 8,700 13 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH Put 0 0 n/a n/a n/a
2024-02-08 2022-03-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F ISHARES TR ISHARES BIOTECH Put 200 26 n/a n/a n/a
2021-08-16 2021-06-30 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-24 2021-03-31 13F ISHARES TR NASDAQ BIOTECH Put 400 1 n/a n/a n/a
2020-01-29 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-29 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF Put 1,100 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.